Share Twitter LinkedIn Facebook Email Do-Youn Oh, M.D., of Seoul National University Hospital discusses Pembrolizumab Monotherapy In Biliary Cancer. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.
FDA Approves TEVIMBRA for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma Gastrointestinal 3 Mins Read
Why isn’t CAR-T Therapy Revolutionizing the Fight Against GI Cancers? 17 Trial Insights from ASCO GI 2025 Gastrointestinal 4 Mins Read
Nivolumab + Ipilimumab Shows Improved Outcomes in MSI-H/dMMR mCRC CheckMate-8HW Trial ASCO GI 2 Mins Read
